Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 21, Issue 4, 1998, Pages 347-351

  Vadell, Catalina ^a   Seguí, Miguel Angel ^b   Giménez Arnau, José María ^c   Morales, Serafín ^d   Cirera, Luis ^e   Bestit, Isabel ^c   Batiste, Eduardo ^f   Blanco, Remei ^g   Jolis, Laura ^h   Boleda, Montserrat ⁱ   Antón, Isabel ^j  

^a HOSPITAL DEL MAR   (Spain)

^b Department of Pediatrics   (Spain)

^c Prasfarma SA   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e HOSPITAL MÚTUA DE TERRASSA   (Spain)

^f HOSPITAL GENERAL DE VIC   (Spain)

^g HOSPITAL DE TERRASSA   (Spain)

^h HOSPITAL GENERAL DE GRANOLLERS   (Spain)

ⁱ Hospital Sant Camil   (Spain)

^j Hospital del Mar ^*

more..

Author keywords

Anorexia; Cachexia; Cancer; Megestrol acetate

Indexed keywords

MEGESTROL ACETATE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHYSICAL CAPACITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SKINFOLD THICKNESS;

AGED; ANALYSIS OF VARIANCE; ANOREXIA; APPETITE STIMULANTS; CACHEXIA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEGESTROL ACETATE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; SKINFOLD THICKNESS; WEIGHT GAIN;

EID: 0031819260     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199808000-00006     Document Type: Article

References (23)

1. DeWys WD. Anorexia as a general effect of cancer. Cancer 1972;43:2013-9.
2. Curtis EB, Krech R, Walsh TD. Common symptoms in patients with advanced cancer. J Palliat Care 1991;7:25-9.
3. Grant YP. Preventing complications of surgery: emphasis on nutritional factors. In: Lazlo Y, Dakken M, eds. Physicians guide to cancer complications: prevention and management. New York: Dekker, 1986:48-52.
4. Splinter TAW. Cachexia and cancer: a clinician's view. Ann Oncol 1992;3(suppl 3):S25-7.
5. Bruera E, MacDonald RN. Nutrition in patients with advanced cancer: an update and review of our experience. J Pain Symptom Manage 1988;3:133-40.
6. Lanzotti V, Copeland EM, Bhuchar V, et al. A randomized trial of total parenteral nutrition (TPN) with chemotherapy for non-oat cell cancer [Abstract C-277]. Proceedings of the American Society of Clinical Oncology 1980.
7. Nixon D, Moffitt S, Lawson DH, et al. Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treatment Reports 1981;65(suppl 5):121-8.
8. Serrou B, Cupissol D, Plagne R, et al. Parenteral intravenous nutrition (PNN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma. Cancer Treatment Reports 1981;65(suppl 5):151-5.
9. Kardinal CG, Loprinzi CL, Schaid DJ, et al. A controlled trial of ciproheptadine in cancer patients with anorexia and/or cachexia. Cancer 1990;65:2657-62.
10. Chlebowski RT, Bulcavage L, Grosvenor M, et al. Hydralazine sulfate in cancer patients with weight loss: a placebo controlled clinical experience. Cancer 1987;59:406-10.
11. Chlebowski RT, Bulcavage L, Grosvenor M, et al. Hydralazine sulfate influence on nutritional status and survival in non-small cell lung cancer. J Clin Oncol 1990;8:9-15.
12. Wadleigh R, Spaulding GM, Lumbersky B, et al. Dronabinol enhancement of appetite in cancer patients [Abstract 1280]. Proceedings of the American Society of Clinical Oncology 1990; 9:331.
13. Nelson KA, Walsh D, Sheehan FA. The cancer anorexiacachexia syndrome. J Clin Oncol 1994;12:213-25.
14. Goldberg RM, Loprinzi CL, Mailliard JA, et al. Pentoxifylline for treatment of cancer anorexia and cachexia? a randomized, double-blind, placebo-controlled trial. J Clin Oncol 1995; 13:2856-9.
15. Tchekmedian NS, Hickman M, Siau J, et al. Treatment of cancer anorexia with megestrol acetate: impact on quality of life. Oncology 1990;4:185-92.
16. Loprinzi CL, Ellison NM, Schaid DJ, et al. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst 1990;82:1127-32.
17. Bruera E, Macmillan K, Kuehn N, et al. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status and other symptoms in patients with advanced cancer. Cancer 1990;66:1279-82.
18. Feliu J, Gonzalez-Barón M, Berrocal A, et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. a placebo-controlled study. Am J Clin Oncol 1992;15:436-40.
19. Schmoll E, Wilke H, Thole R, et al. Megestrol acetate in cancer cachexia. Semin Oncol 1991;18(suppl 2):32-4.
20. Loprinzi CL, Michalak JC, Schaid DJ, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993;11:762-7.
21. Aisner J, Tchekmedian S, Tait N, et al. Studies of high dose megestrol acetate: potential applications in cachexia. Semin Oncol 1988;15(suppl 21):68-75.
22. Moertel CG, Shutt AJ, Reitemeier Rj, et al. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer 1974;33: 1607-9.
23. Bruera E, Roca E, Cedaro L, et al. Action of oral methylprednisolone in terminal cancer patients: a randomized double blind study. Cancer Treatment Reports 1985;69:751-4.